Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

3 novembre 2008|
Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance de J. Rick Turner
150,95 $
Couverture rigide
Obtenez 755 points privilègeᴹᴰ
Acheter en ligne
Livraison à une adresse
Expédié en 1 à 3 semaines.Expédition gratuite pour les commandes d’au moins 35 $
Cueillette en magasin
Pour savoir si la cueillette en magasin est offerte,
Trouver en magasin
Non vendu en magasin
Les prix et les offres peuvent différer de ceux en magasin

description

The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students.
J. Rick Turner, PhD, PGCE, MICR, is Chairman, Department of Clinical Research at Campbell University School of Pharmacy. Dr. Turner has extensive teaching, research, and pharmaceutical credentials and more than a dozen awards and honors, including a Commit to Product Development Award from GlaxoSmithKline. He is the author of seven boo...
Loading
Titre :Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance
Format :Couverture rigide
Dimensions :500 pages
Publié le :3 novembre 2008
Publié par :Wiley
Langue :anglais
Convient aux âges :Tous les âges
ISBN - 13 :9780470229644

Consulté récemment
|